Delivery Order SPE2DB20D2014-SPE2DB25FC77V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,392.42. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 24, 2025, with completion expected by July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $3,505.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 capsules of Trokendi XR 200 mg, with an ultimate completion date of August 4, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's broader federal contract portfolio supporting military and veteran healthcare...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 25 mg capsules, a neurological medication, with a ceiling value of $8,079.37 and a period of performance through April 17, 2025. The contract is not set-aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trokendi XR 50 mg capsules, with a ceiling value of $1,557.85 and a completion date of June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This federal contract award, valued at $3,640.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a medication used to treat certain neurological conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open...
- This is a $1,084.82 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of Trokendi XR 100 mg capsules to support DLA Troop Support Medical programs. AmerisourceBergen Drug Corp, through its Corporate Office division, regularly provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a neurological medication, with a ceiling value of $1,436.67. The contract is a firm fixed-price, non-set-aside arrangement with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a $12,336.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The award has no set-aside designation and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical...
- The Defense Logistics Agency awarded a $463 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100mg capsules of Trokendi XR. The delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 30 capsules to be delivered to a location in Conshohocken, Pennsylvania by July 13, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC77VDelivery Order
The Defense Logistics Agency awarded a $3,379.08 delivery order to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Trokendi XR is a brand-name neurological medication used primarily for seizure management and migraine prevention, representing part of the company's broader pharmaceutical supply portfolio to federal medical systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and related healthcare commodities to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through open competition across delivery orders ranging from minimal to substantial values, positioning the company as a critical vendor for the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/18/25 |